
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-5775
Dr. Howard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Howard III is a Resident Physician based in Boston, MA. He completed his medical education at Harvard Medical School in the class of 2021. Prior to medical school, he obtained a BS/MS in Biology, graduating Magna Cum Laude from Yale University in 2012, and a PhD in Biological and Biomedical Sciences from Harvard Graduate School of Arts and Sciences in 2019. Dr. Howard has authored several publications, including work on magnetic resonance-guided radiation therapy and proton radiation therapy, with his research appearing in notable journals such as the International Journal of Radiation Oncology, Biology, Physics, JCO Oncology Practice, Pediatric Blood & Cancer, Genome Medicine, and Molecular Cell. His work has contributions that have been cited multiple times in other publications.
Education & Training
- Harvard Medical SchoolClass of 2021
- Harvard Graduate School of Arts and SciencesPhD, Biological and Biomedical Sciences, 2014 - 2019
- Yale UniversityBS/MS, Biology, Magna Cum Laude, 2008 - 2012
Certifications & Licensure
- MA State Medical License 2021 - 2026
Publications & Presentations
PubMed
- Magnetic Resonance-Guided Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation for Reirradiation in the Abdomen.Thomas P Howard, Dianne Ferguson, Zhaohui Han, Harvey J Mamon, Jonathan E Leeman
International Journal of Radiation Oncology, Biology, Physics. 2025-03-31 - Evolving Role of Proton Radiation Therapy in Clinical Practice.Thomas P Howard, Shearwood McClelland 3rd, Rachel B Jimenez
JCO Oncology Practice. 2024-06-01 - 2 citationsClinical outcomes for pediatric patients receiving radiotherapy for solid tumor central nervous system metastases.Thomas P Howard, Patrick J. Boyle, Karen J. Marcus, Daphne A. Haas-Kogan, Kevin X. Liu
Pediatric Blood & Cancer. 2021-09-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: